SCHEMBL21373530

SCHEMBL21373530

[c]1cncnc1-c1ccc2cn[nH]c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 11/20 0.50
FGFR2 P21802 5/20 0.49
FGFR3 P22607 2/20 0.49
DYRK1A Q13627 3/20 0.45
MAPK1 P28482 2/20 0.45
ABL1 P00519 2/20 0.45
SRC P12931 2/20 0.45
KDR P35968 2/20 0.45
PLK4 O00444 1/20 0.45
CHEK1 O14757 1/20 0.45
PDPK1 O15530 1/20 0.45
DYRK3 O43781 1/20 0.45
JAK2 O60674 1/20 0.45
ROCK2 O75116 1/20 0.45
PRKD3 O94806 1/20 0.45
MAP4K4 O95819 1/20 0.45
NTRK1 P04629 1/20 0.45
INSR P06213 1/20 0.45
FYN P06241 1/20 0.45
CDK1 P06493 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21373660 0.75 FGFR1 (0.50) FGFR1FGFR2FGFR3DYRK1AMAPK1
SCHEMBL28200925 0.75 FGFR1 (0.54) FGFR1FGFR2FGFR3DYRK1AMAPK1
SCHEMBL1318366 0.73 FGFR1 (0.55) FGFR1FGFR2FGFR3DYRK1AMAPK1
SCHEMBL20385993 0.71 FGFR1 (0.55) FGFR1FGFR2FGFR3DYRK1AMAPK1
SCHEMBL21373604 0.70 QPCT (0.37) KDM4EMAPT
SCHEMBL27976107 0.69 CLK1 (0.74) FGFR1FGFR2FGFR3DYRK1AMAPK1
SCHEMBL21565626 0.68 ABL1 (0.51) FGFR1FGFR2FGFR3DYRK1AMAPK1
SCHEMBL20380290 0.68 FGFR1 (0.50) FGFR1FGFR2FGFR3DYRK1AMAPK1
SCHEMBL20386115 0.68 FGFR1 (0.51) FGFR1FGFR2FGFR3DYRK1AMAPK1
SCHEMBL2460902 0.67 FGFR1 (1.00) FGFR1FGFR2FGFR3DYRK1AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3543231-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH Zurich (CH) 2019-09-25 EP claimed
EP-3568133-B1 CELL-PROTECTIVE COMPOUNDS AND THEIR USE ETH ZUERICH (CH) 2023-12-13 EP disclosed
CN-116462666-A Cytoprotective compounds and uses thereof 瑞士苏黎世联邦理工学院 2023-07-21 CN disclosed
EP-3543231-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH Zurich (CH) 2019-09-25 EP disclosed